...
首页> 外文期刊>Drug Design, Development and Therapy >Annatto-Derived Tocotrienol Promotes Mineralization of MC3T3-E1 Cells by Enhancing BMP-2 Protein Expression via Inhibiting RhoA Activation and HMG-CoA Reductase Gene Expression
【24h】

Annatto-Derived Tocotrienol Promotes Mineralization of MC3T3-E1 Cells by Enhancing BMP-2 Protein Expression via Inhibiting RhoA Activation and HMG-CoA Reductase Gene Expression

机译:通过抑制RhOA活化和HMG-COA还原酶基因表达,通过提高BMP-2蛋白表达来促进MC3T3-E1细胞的矿化,促进MC3T3-E1细胞的矿化

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose: Annatto-derived tocotrienol (AnTT) has been shown to improve bone formation in animal models of osteoporosis and promote differentiation of pre-osteoblastic cells. However, the mechanism of action of AnTT in achieving these effects is unclear. This study aims to investigate the mechanism of action of AnTT on MC3T3-E1 pre-osteoblasts via the mevalonate pathway. Methods: Murine pre-osteoblastic cells, MC3T3-E1, were cultured with the density of 1 × 10sup4/sup cells/mL and treated with 4 concentrations of AnTT (0.001– 1 μg/mL). Expression of HMG-CoA reductase (HMGR) gene was carried out using qPCR after treatment with AnTT for 21 days. RhoA activation and bone morphogenetic protein-2 (BMP-2) were measured using immunoassay after 9 and 15 days of AnTT treatment. Lovastatin was used as the positive control. Mineralized nodules were detected using Von Kossa staining after 21 days of AnTT treatment. Results: The results showed that HMGR was up-regulated in the lovastatin group on day 9 and 21 compared to the control. Lovastatin also inhibited RhoA activation (day 9 and 15) and increased BMP-2 protein (day 15). On the other hand, AnTT at 0.001 μg/mL (day 3) and 0.1 μg/mL (day 21) significantly down-regulated HMGR gene expression compared to the control. On day 21, HMGR gene expression was significantly reduced in all groups compared to day 15. AnTT at 0.1 μg/mL significantly decreased RhoA activation on day 9 compared to the control. AnTT at 1 μg/mL significantly increased BMP-2 protein on day 15 compared to the control (P 0.05). Mineralized calcium nodules were more abundant in AnTT treated groups compared to the control on day 21. Conclusion: AnTT suppresses the mevalonate pathway by downregulating HMGR gene expression and inhibiting RhoA activation, leading to increased BMP-2 protein in MC3T3-E1 cells. This explains the stimulating effects of AnTT on osteoblast mineralization.
机译:目的:已显示Annatto衍生的Tocotrienol(antt),以改善骨质疏松症的动物模型中的骨形成,促进骨细胞预骨细胞的分化。然而,休闲作用机制在实现这些效果方面尚不清楚。本研究旨在通过甲丙酸盐途径探讨抗甲虫对MC3T3-E1预成骨细胞的作用机理。方法:鼠预骨细胞MC3T3-E1培养,密度为1×10 4℃/ ml,并用4个浓度的抗体(0.001-1μg/ ml)处理。用QPCR在用抗体处理后进行HMG-CoA还原酶(HMGR)基因的表达21天。使用免疫测定在休闲处理后的免疫测定法测量RhoA活化和骨形态发生蛋白-2(BMP-2)。洛伐他汀被用作阳性对照。使用von Kossa染色在21天后的髌骨处理后检测矿化结节。结果:结果表明,与对照相比,第9天和第21天在洛伐他汀组中调节HMGR。 Lovastatin还抑制了RhoA活化(第9天和第15天),增加了BMP-2蛋白(第15天)。另一方面,与对照相比,在0.001μg/ ml(第3天)和0.1μg/ ml(第21天)的抗塔,显着下调HMGR基因表达。在第21天,与第15天相比,所有基团的HMGR基因表达显着降低。与对照相比,在第9天时,0.1μg/ ml的抗滴度显着降低了RHOA活化。与对照相比,第15天在1μg/ ml时,1μg/ ml的抗体显着增加(P <0.05)。与第21天的对照相比,矿化钙结节在抗体治疗组中更丰富。结论:通过下调HMGR基因表达并抑制RHOA活化,抗抑制甲戊酸途径,导致MC3T3-E1细胞中的BMP-2蛋白增加。这解释了邻型对成骨细胞矿化的刺激作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号